BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-10 out of 10 found
  Current Search:  anemia: 583, hemolytic: 10, autoimmune: 59     

HTML
66%
First Clinical Experience With Soliris in Treating Patients With Two Rare Complement-Mediated Diseases Present
Effects of Complement Inhibition With Eculizumab Observed in Patients with Atypical Hemolytic Uremic Syndrome (aHUS) and Cold Agglutinin Disease (CAD) CHESHIRE, Conn., December 07, 2008 /PRNewswire-FirstCall/-- Soliris(R) (eculizumab),...
Pharma Live:  Dec 9 2008 3:23PM
Matching: anemia hemolytic
Find similar documents
HTML
66%
First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Pres
CHESHIRE, Conn.

Physicians reported on the first clinical experience with Soliris in patients with atypical Hemolytic Uremic Syndrome (aHUS) and Cold Agglutinin Disease (CAD), two rare and serious diseases.

Like patients with PNH,...

Genetic Engineering News:  Dec 7 2008 7:30PM
Matching: anemia hemolytic
Find similar documents
HTML
66%
First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Pres
Effects of Complement Inhibition With Eculizumab Observed in Patients with Atypical Hemolytic Uremic Syndrome (aHUS) and Cold Agglutinin Disease (CAD) CHESHIRE, Conn., Dec.

7 /PRNewswire-FirstCall/-- Soliris(R) (eculizumab), a...

KLFY:  Dec 7 2008 8:54PM
Matching: anemia hemolytic
Find similar documents
HTML
66%
First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Pres
Effects of Complement Inhibition With Eculizumab Observed in Patients with Atypical Hemolytic Uremic Syndrome (aHUS) and Cold Agglutinin Disease (CAD) CHESHIRE, Conn., Dec.

7 /PRNewswire-FirstCall/-- Soliris(R) (eculizumab), a...

KOTA Territory News:  Dec 7 2008 7:50PM
Matching: anemia hemolytic
Find similar documents
HTML
66%
First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Pres
Effects of Complement Inhibition With Eculizumab Observed in Patients with Atypical Hemolytic Uremic Syndrome (aHUS) and Cold Agglutinin Disease (CAD) CHESHIRE, Conn., Dec.

7 /PRNewswire-FirstCall/-- Soliris(R) (eculizumab), a...

Montana's News Station:  Dec 7 2008 7:27PM
Matching: anemia hemolytic
Find similar documents
HTML
66%
First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Pres
Effects of Complement Inhibition With Eculizumab Observed in Patients with Atypical Hemolytic Uremic Syndrome (aHUS) and Cold Agglutinin Disease (CAD) CHESHIRE, Conn., Dec.

7 /PRNewswire-FirstCall/-- Soliris(R) (eculizumab), a...

KSLA:  Dec 7 2008 6:49PM
Matching: anemia hemolytic
Find similar documents
HTML
100%
IMHA: Diagnosing and treating a complex disease
Differentiating IMHA from other causes of hemolytic anemia is challenging, but a careful diagnostic process will help you determine whether your veterinary patients will require long-term immunosuppressive therapy.

Dec 1, 2008...

Thomson Veterinary Healthcare Communications:  Dec 6 2008 4:19PM
Matching: anemia hemolytic autoimmune
Find similar documents
HTML
66%
Biovitrum and Symphogen Report Positive Clinical Results in Novel Rh-immunization Prevention Project
Biovitrum AB (publ) (STO:BVT) and Symphogen A/S have completed the first part of a clinical proof of mechanism study of the recombinant human polyclonal antibody product Sym001 for future prevention of Hemolytic Disease of the Newborn ...
Pharma Live:  Nov 20 2008 6:04PM
Matching: anemia hemolytic
Find similar documents
HTML
58%
Inhibition of complement activation
Title: United States Patent: 7,439,331 Inventors: Fung; Michael S.

(Houston, TX), Sun; William N.

(Bellaire, TX), Sun; Cecily R.

(Bellaire, TX) Assignee: Genentech, Inc.

(South San Francisco, CA) Appl.

No.: 11/478,089 Filed: June...

PharmCast:  Nov 5 2008 8:57PM
Matching: anemia autoimmune
Find similar documents
HTML
58%
Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
Title: United States Patent: 7,429,570 Inventors: Seidman; Ernest G.

(Cote St.

Luc, CA), Theoret; Yves (Montreal, CA) Assignee: Hopital Sainte-Justine (Montreal, Quebec, CA) Appl.

No.: 11/689,472 Filed: March 21, 2007 The present...

PharmCast:  Oct 15 2008 8:23PM
Matching: anemia autoimmune
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.